Poland· PL-100382300
Nifelox
A solifenacin product containing solifenacini succinas, registered in Poland by Synoptis Pharma Sp. z o.o.. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Solifenacin is registered in 18 of 19 countries.
Countries holding a registration under ATC G04BD08 (solifenacin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Solifenacin · ATC G04BD08
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of solifenacin costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.25 in France to $0.92 in Switzerland — a ×3.7 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Solifenacin · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.92
- ES Spain$0.77
- IT Italy$0.59
- FR France$0.25
The record
At a glance
URPL (Poland)- Active substance
- Solifenacini succinas
- Manufacturer
- Synoptis Pharma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- G04BD08
- ATC class
- Solifenacin
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991400651
- gtin05909991400668
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
315 interactions on record for solifenacin.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Solifenacin · interactions on record
315 records
- 50 severe
- 210 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Potassium chlorideA12BA01severe
52 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Solifenacin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARUSOLARDEZ Pharma, spol. s r.o., Kosoř
- SpainASOLFENA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGKrka D.D. Novo Mesto
- United Statessolifenacin succinateAjanta Pharma USA Inc.
- NetherlandsSolifenacine Aurobindo 5 mg, filmomhulde tablettenAurobindo Pharma B.V.
- FranceSOLIFENACINE ACCORD 5 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- ItalyINCOVESLAMPUGNANI FARMACEUTICI S.P.A.
- SwitzerlandSolifenacin NOBEL 5 mg, FilmtablettenNOBEL Pharma Schweiz AG
- FinlandSolifenacin AccordAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Solifenacin +pharma, Solifenacin 1a Pharma
- Belgium · Pelvicare, Solifenacin Ab
- Bulgaria · Truzor, Асолфена
- Cyprus · Saprax, Solifenacin Accord
- Czechia · Arusol, Asolfena
- Germany · Solifemin, Solifenacin 1 A Pharma
- Denmark · Solifenacin "sandoz", Solifenacin Krka
- Estonia · Asolfena, Solifenacin Nobel
- Spain · Dicrisol, Sincal
- Finland · Solifenacin Accord, Solifenacin Krka
- France · Solifenacine Accord, Solifenacine Arrow
- United Kingdom (Northern Ireland) · Seylacine Solifenacin Succinate, Solifenacin Jubilant Pharmaceuticals
- Greece · Cecure, Nacerfin
- Croatia · Asolfena, Beloflux
- Hungary · Asolfena, Belsanor
- Ireland · Solifenacin Clonmel, Solifenacin Succinate Accord Healthcare Ireland
- Iceland · Solifenacin Alvogen, Solifenacin Krka
- Italy · Incoves, Orodax
- Liechtenstein · Vesicare
- Lithuania · Asolfena, Gardurin
- Luxembourg · Pelvicare, Solifenacin Ratiopharm
- Latvia · Asolfena, Gardurin
- Malta · Solifenacin Pharmsol, Vesicare
- Netherlands · Solifenacinesuccinaat Accord, Solifenacinesuccinaat Aurobindo
- Norway · Solifenacin Accord, Solifenacin Krka
- Portugal · Blaxi, Solifenacina Alter
- Romania · Asolfena, Solifenacin Msn Laboratories
- Sweden · Solifenacin Accord, Solifenacin Glenmark
- Slovenia · Asolfena, Solifenacin Lek
- Slovakia · Aristissa, Arusol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1badf381-c7cd-453a-9c9d-d00100ec9f7c GET /v1/drugs/1badf381-c7cd-453a-9c9d-d00100ec9f7c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "5 mg",
"packaging": "05909991400651 ¦ Rp ¦ 129046\n30 tabl.\n05909991400668 ¦ Rp ¦ 129047\n90 tabl.",
"substance": "Solifenacini succinas 5 mg",
"common_name": "Solifenacini succinas",
"pl_product_id": "100382300",
"pozwolenie_nr": "25262",
"auth_procedure": "NAR",
"authorisation_validity": "2023-10-19"
}See everything about solifenacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.